Fundraising Fox
Ractigen
Suzhou, CN · Founded 2017 · 21 employees on LinkedIn · 2 known investors
Find your way into Ractigen
Sign up to see every warm intro you have to Ractigen
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Ractigen team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Ractigen Therapeutics develops proprietary RNA delivery platforms for oligonucleotide therapeutics, enabling treatment of previously unreachable tissues and organs in the CNS and beyond the liver. The company's platforms support clinical development of RNA-based therapies through simplified manufacturing processes.
Founders & leadership
Ractigen was founded in 2017 by Dr. Long-Cheng Li.
DL
Dr. Long-Cheng LiCEO and Founder
DM
Dr. Moorim KangChief Technology Officer
Investors · 2
SDIC Venture Capital✓ confirmed by RactigenBeijing
How we know: the company's own site · funding news · press coverage · Not right? Tell us
In the news
Frequently asked questions
- What does Ractigen do?
- Ractigen Therapeutics develops proprietary RNA delivery platforms for oligonucleotide therapeutics, enabling treatment of previously unreachable tissues and organs in the CNS and beyond the liver. The company's platforms support clinical development of RNA-based therapies through simplified manufacturing processes.
- Who founded Ractigen?
- Ractigen was founded by Dr. Long-Cheng Li in 2017.
- Who are Ractigen's investors?
- Ractigen's investors include SDIC Venture Capital, Eisai Innovation, Inc..
- Where is Ractigen headquartered?
- Ractigen is headquartered in Suzhou, CN.